---
title: "Accendra Health Shareholders Approve Amended Omnibus Incentive Plan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286571369.md"
description: "Accendra Health shareholders approved an Amended Omnibus Incentive Plan at the May 14, 2026 meeting, allowing the Board to issue equity awards. Six directors were elected, KPMG LLP was ratified as auditor, and executive compensation was endorsed. Analysts rate ACH stock as a Buy with a $6.00 target, though Spark's AI Analyst gives it a Neutral rating due to weak financial performance and challenges in valuation."
datetime: "2026-05-15T13:05:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286571369.md)
  - [en](https://longbridge.com/en/news/286571369.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286571369.md)
---

# Accendra Health Shareholders Approve Amended Omnibus Incentive Plan

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Accendra Health ( (ACH) ) has provided an update.

At its May 14, 2026 Annual Meeting of Shareholders, Accendra Health, Inc. reported that investors approved an Amended and Restated 2023 Omnibus Incentive Plan, replacing the prior Owens & Minor, Inc. 2023 plan and empowering the Board’s People & Culture Committee to issue equity and other incentive awards to employees, non-employee directors, and consultants under individualized award agreements. Shareholders also elected six directors to one-year terms, ratified KPMG LLP as independent auditor for the 2026 fiscal year, and endorsed, on an advisory basis, the compensation of named executive officers, signaling broad investor support for the company’s leadership, compensation framework, and refreshed long-term incentive structure.

The most recent analyst rating on (ACH) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on Accendra Health stock, see the ACH Stock Forecast page.

**Spark’s Take on ACH Stock**

According to Spark, TipRanks’ AI Analyst, ACH is a Neutral.

The score is held down primarily by weak financial performance (sharp revenue contraction, large losses, negative equity, and negative recent free cash flow). The earnings call provides some offset via affirmed 2026 outlook, liquidity, and a pending balance-sheet optimization that extends maturities and could reduce leverage, but higher expected interest expense and recent cash-flow pressure remain key constraints. Technicals are mixed and do not provide a strong momentum tailwind, while valuation is challenged by ongoing losses and no dividend support.

To see Spark’s full report on ACH stock, click here.

**More about Accendra Health**

Accendra Health, Inc., formerly operating under the Owens & Minor, Inc. incentive plan framework, is a healthcare-focused company that utilizes equity and other incentive awards to attract and retain employees, non-employee directors, and consultants. The company’s governance structure includes a Board-level People & Culture Committee responsible for administering its omnibus incentive plans to align stakeholder and management interests.

**Average Trading Volume:** 885,851

**Technical Sentiment Signal:** Sell

**Current Market Cap:** $232.8M

### Related Stocks

- [ACH.US](https://longbridge.com/en/quote/ACH.US.md)
- [OMI.US](https://longbridge.com/en/quote/OMI.US.md)

## Related News & Research

- [TRIPO Launches Tripo Studio AI-Powered 3D Creation Platform](https://longbridge.com/en/news/286665165.md)
- [Do Wall Street Analysts Like Otis Worldwide Stock?](https://longbridge.com/en/news/286568841.md)
- [Employers set to rapidly expand AI use in health and benefits, but execution gaps remain, WTW survey finds | WTW Stock News](https://longbridge.com/en/news/286925133.md)
- [Glytec and Advocate Health Win Top Innovation Award for Pediatric Insulin Safety](https://longbridge.com/en/news/286946637.md)
- [Stocks in Play: WELL Health Technologies Corp.](https://longbridge.com/en/news/286934552.md)